UOC
OCAT

UBS O'Connor’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

UBS O'Connor’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-199,600
Closed -$1.05M – 879
2015
Q2 		$1.05M Buy
+199,600
New +$1.28M 0.01% 574

Other funds holding OCAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS O'Connor's OCAT Position: Q3 2015 in Review

UBS O'Connor sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q3 2015, closing a stake of 199,600 shares — an estimated $1.05M sold.

UBS O'Connor first reported a position in OCAT in Q2 2015 and held it in 1 quarter. The position peaked at $1.05M in Q2 2015. 63 funds tracked by Wall St. Rank hold OCAT as of Q3 2015.

  • UBS O'Connor reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • UBS O'Connor sold 199,600 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q3 2015, an estimated $1.05M.
  • UBS O'Connor first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 1 quarter.
  • UBS O'Connor's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $1.05M in Q2 2015.
  • 63 funds tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q3 2015.

Based on UBS O'Connor's 13F filing for Q3 2015, filed 13 Nov 2015.